These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 30600817)

  • 21. New RuII (arene) complexes with halogen-substituted bis- and tris(pyrazol-1-yl)borate ligands.
    Orbisaglia S; Di Nicola C; Marchetti F; Pettinari C; Pettinari R; Martins LM; Alegria EC; da Silva MF; Rocha BG; Kuznetsov ML; Pombeiro AJ; Skelton BW; Sobolev AN; White AH
    Chemistry; 2014 Mar; 20(13):3689-704. PubMed ID: 24616192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eta6-mesityl,eta1-imidazolinylidene-carbene-ruthenium(II) complexes: catalytic activity of their allenylidene derivatives in alkene metathesis and cycloisomerisation reactions.
    Cetinkaya B; Demir S; Ozdemir I; Toupet L; Sémeril D; Bruneau C; Dixneuf PH
    Chemistry; 2003 May; 9(10):2323-30. PubMed ID: 12772307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chlorido-, aqua-, 9-ethylguanine- and 9-ethyladenine-adducts of cytotoxic ruthenium arene complexes containing O,O-chelating ligands.
    Melchart M; Habtemariam A; Parsons S; Sadler PJ
    J Inorg Biochem; 2007 Nov; 101(11-12):1903-12. PubMed ID: 17582501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correction: One pot ligand exchange method for a highly stable Au-SBA-15 catalyst and its room temperature CO oxidation.
    Soni Y; Kavya I; Ajithkumar TG; Vinod CP
    Chem Commun (Camb); 2018 Nov; 54(91):12892. PubMed ID: 30394461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, characterization, and antitumor activity of water-soluble (arene)ruthenium(II) derivatives of 1,3-dimethyl-4-acylpyrazolon-5-ato ligands. First example of Ru(arene)(ligand) antitumor species involving simultaneous Ru-N7(guanine) bonding and ligand intercalation to DNA.
    Caruso F; Monti E; Matthews J; Rossi M; Gariboldi MB; Pettinari C; Pettinari R; Marchetti F
    Inorg Chem; 2014 Apr; 53(7):3668-77. PubMed ID: 24611608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microwave-assisted synthesis of arene ruthenium(II) complexes [(η⁶-RC₆H₅)Ru(m-MOPIP)Cl]Cl (R = -H and -CH₃) as groove binder to c-myc G4 DNA.
    Wu Q; Chen T; Zhang Z; Liao S; Wu X; Wu J; Mei W; Chen Y; Wu W; Zeng L; Zheng W
    Dalton Trans; 2014 Jun; 43(24):9216-25. PubMed ID: 24818221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of oxygenation on the reactivity of ruthenium-thiolato bonds in arene anticancer complexes: insights from XAS and DFT.
    Sriskandakumar T; Petzold H; Bruijnincx PC; Habtemariam A; Sadler PJ; Kennepohl P
    J Am Chem Soc; 2009 Sep; 131(37):13355-61. PubMed ID: 19719101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Competition between glutathione and guanine for a ruthenium(II) arene anticancer complex: detection of a sulfenato intermediate.
    Wang F; Xu J; Habtemariam A; Bella J; Sadler PJ
    J Am Chem Soc; 2005 Dec; 127(50):17734-43. PubMed ID: 16351102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ferrocenoyl pyridine arene ruthenium complexes with anticancer properties: synthesis, structure, electrochemistry, and cytotoxicity.
    Auzias M; Therrien B; Süss-Fink G; Stepnicka P; Ang WH; Dyson PJ
    Inorg Chem; 2008 Jan; 47(2):578-83. PubMed ID: 18085776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversible pH-Responsive Behavior of Ruthenium(II) Arene Complexes with Tethered Carboxylate.
    Martínez-Peña F; Infante-Tadeo S; Habtemariam A; Pizarro AM
    Inorg Chem; 2018 May; 57(9):5657-5668. PubMed ID: 29688005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic oxygen atom transfer by ruthenium complexes with non-redox metal ions.
    Lv Z; Zheng W; Chen Z; Tang Z; Mo W; Yin G
    Dalton Trans; 2016 Jul; 45(28):11369-83. PubMed ID: 27333442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual-targeting organometallic ruthenium(II) anticancer complexes bearing EGFR-inhibiting 4-anilinoquinazoline ligands.
    Zhang Y; Zheng W; Luo Q; Zhao Y; Zhang E; Liu S; Wang F
    Dalton Trans; 2015 Aug; 44(29):13100-11. PubMed ID: 26106875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Switching between kappa(2) and kappa(3) bis(pyrazol-1-yl)acetate ligands by tuning reaction conditions: synthesis, spectral, electrochemical, structural, and theoretical studies on arene-Ru(II) derivatives of bis(azol-1-yl)acetate ligands.
    Marchetti F; Pettinari C; Cerquetella A; Cingolani A; Pettinari R; Monari M; Wanke R; Kuznetsov ML; Pombeiro AJ
    Inorg Chem; 2009 Jul; 48(13):6096-108. PubMed ID: 19507885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Am(m)ines make the difference: organoruthenium am(m)ine complexes and their chemistry in anticancer drug development.
    Babak MV; Meier SM; Legin AA; Adib Razavi MS; Roller A; Jakupec MA; Keppler BK; Hartinger CG
    Chemistry; 2013 Mar; 19(13):4308-18. PubMed ID: 23341078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3-Hydroxyflavones vs. 3-hydroxyquinolinones: structure-activity relationships and stability studies on Ru(II)(arene) anticancer complexes with biologically active ligands.
    Kurzwernhart A; Kandioller W; Enyedy ÉA; Novak M; Jakupec MA; Keppler BK; Hartinger CG
    Dalton Trans; 2013 May; 42(17):6193-202. PubMed ID: 23168616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strong Influence of Ancillary Ligands Containing Benzothiazole or Benzimidazole Rings on Cytotoxicity and Photoactivation of Ru(II) Arene Complexes.
    Lari M; Martínez-Alonso M; Busto N; Manzano BR; Rodríguez AM; Acuña MI; Domínguez F; Albasanz JL; Leal JM; Espino G; García B
    Inorg Chem; 2018 Nov; 57(22):14322-14336. PubMed ID: 30379535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of the structural determinants for anticancer activity of a ruthenium arene peptide conjugate.
    Meier SM; Novak M; Kandioller W; Jakupec MA; Arion VB; Metzler-Nolte N; Keppler BK; Hartinger CG
    Chemistry; 2013 Jul; 19(28):9297-307. PubMed ID: 23712572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From Catalysis to Cancer: Toward Structure-Activity Relationships for Benzimidazol-2-ylidene-Derived N-Heterocyclic-Carbene Complexes as Anticancer Agents.
    Lam NYS; Truong D; Burmeister H; Babak MV; Holtkamp HU; Movassaghi S; Ayine-Tora DM; Zafar A; Kubanik M; Oehninger L; Söhnel T; Reynisson J; Jamieson SMF; Gaiddon C; Ott I; Hartinger CG
    Inorg Chem; 2018 Nov; 57(22):14427-14434. PubMed ID: 30406647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenylazo-pyridine and phenylazo-pyrazole chlorido ruthenium(II) arene complexes: arene loss, aquation, and cancer cell cytotoxicity.
    Dougan SJ; Melchart M; Habtemariam A; Parsons S; Sadler PJ
    Inorg Chem; 2006 Dec; 45(26):10882-94. PubMed ID: 17173447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upconverting Nanoparticles Prompt Remote Near-Infrared Photoactivation of Ru(II)-Arene Complexes.
    Ruggiero E; Garino C; Mareque-Rivas JC; Habtemariam A; Salassa L
    Chemistry; 2016 Feb; 22(8):2801-11. PubMed ID: 26785101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.